Cytotoxic Effect of Doxorubicin on Human Multiple Myeloma Cells In Vitro

被引：2

作者：

Shushanov, S. S. ^{[1
]}

Kravtsova, T. A. ^{[1
]}

机构：

[1] Russian Acad Med Sci, Inst Carcinogenesis, NN Blokhin Canc Res Ctr, Moscow, Russia

来源：

BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE | 2013年 / 155卷 / 02期

关键词：

multiple myeloma; doxorubicin; insulin; gene expression; MULTIDRUG-RESISTANCE; GROWTH-FACTOR; INSULIN;

D O I：

10.1007/s10517-013-2120-6

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Cytotoxic effect of doxorubicin in human multiple myeloma cell cultures RPMI 1640, RPMI 8226, and IM-9 was studied. The obtained data were compared with mRNA expression of MDR1, MRP1, BCRP, LRP genes responsible for the development of multiple drug resistance. IM-9 cells that differed from the other two cultures by the expression of surface differentiation markers and by mRNA expression of MDR1, BCRP, and LRP were most sensitive to doxorubicin. All cells expressed mRNA for only A-isoform of insulin receptor (IRA), while B-isoform (IRB) was not expressed. Insulin in a concentration of 5 mu g/ml had no effect on the cytotoxic effect of doxorubicin in the studied cells.

引用

页码：228 / 232

页数：5

共 50 条

[1] Cytotoxic Effect of Doxorubicin on Human Multiple Myeloma Cells In Vitro
S. S. Shushanov
T. A. Kravtsova
Bulletin of Experimental Biology and Medicine, 2013, 155 : 228 - 232
[2] Insulin Effects on Survival of Human Multiple Myeloma Cells
Shushanov, S. S.
Kravtsova, T. A.
Chernykh, Yu. B.
Cheikina, N. N.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2015, 159 (02) : 262 - 265
[3] Selective targeting of immunoliposomal doxorubicin against human multiple myeloma in vitro and ex vivo
de Menezes, DEL
Pilarski, LM
Belch, AR
Allen, TM
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2000, 1466 (1-2): : 205 - 220
[4] Knockdown of DEPTOR induces apoptosis, increases chemosensitivity to doxorubicin and suppresses autophagy in RPMI-8226 human multiple myeloma cells in vitro
Zhang, Haoran
Chen, Junmin
Zeng, Zhiyong
Que, Wenzhong
Zhou, Linying
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2013, 31 (05) : 1127 - 1134
[5] Insulin Effects on Survival of Human Multiple Myeloma Cells
S. S. Shushanov
T. A. Kravtsova
Yu. B. Chernykh
N. N. Cheikina
Bulletin of Experimental Biology and Medicine, 2015, 159 : 262 - 265
[6] Cytotoxicity of graphene oxide and graphene oxide loaded with doxorubicin on human multiple myeloma cells
Wu, Shaoling
Zhao, Xindong
Cui, Zhongguang
Zhao, Chunting
Wang, Yuzhen
Du, Li
Li, Yanhui
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2014, 9 : 1413 - 1421
[7] Combined treatment of human multiple myeloma cells with bortezomib and doxorubicin alters the interactome of 20S proteasomes
Mittenberg, Alexey G.
Kuzyk, Valeria O.
Shabelnikov, Sergey V.
Gorbach, Daria P.
Shatrova, Alla N.
Fedorova, Olga A.
Barlev, Nickolai A.
CELL CYCLE, 2018, 17 (14) : 1745 - 1756
[8] Cytotoxic and Apoptotic Effects of Pinostilbene and Bortezomib Combination Treatment on Human Multiple Myeloma Cells
Staskiewicz, Anna
Wong, Erica
Tucker, Michael
Farhin, Riya
Park, Jonathan
Saade, Rana
Alkhazali, Tina
Dang, Tu
Wang, Xinyu
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (16)
[9] Peroxisome proliferator-activated receptor γ agonists potentiate the cytotoxic effect of valproic acid in multiple myeloma cells
Aouali, Nassera
Palissot, Valerie
El-Khoury, Victoria
Moussay, Etienne
Janji, Bassam
Pierson, Sandrine
Brons, Nicolaas H. C.
Kellner, Laurent
Bosseler, Manon
Van Moer, Kris
Berchem, Guy
BRITISH JOURNAL OF HAEMATOLOGY, 2009, 147 (05) : 662 - 671
[10] Cytotoxic effect of conjugates of doxorubicin and human chorionic gonadotropin (hCG) in breast cancer cells
Gebauer, G
Fehm, T
Beck, EP
Berkholz, A
Licht, P
Jäger, W
BREAST CANCER RESEARCH AND TREATMENT, 2003, 77 (02) : 125 - 131

← 1 2 3 4 5 →